These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8573581)

  • 1. Circular dichroism spectroscopy of monoclonal antibodies that bind a superpotent guanidinium sweetener ligand.
    Tetin SY; Linthicum DS
    Biochemistry; 1996 Jan; 35(4):1258-64. PubMed ID: 8573581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of two anti-sweetener single chain antibodies using radioligand binding, fluorescence and circular dichroism spectroscopy.
    Pledger DW; Brodnicki TC; Graham BL; Tetin S; Kranz DM; Linthicum DS
    J Mol Recognit; 1999; 12(4):258-66. PubMed ID: 10440997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of residues in monoclonal antibody NC10.8 that bind to the sweetener N-(p-cyanophenyl)-N'-(diphenylmethyl)guanidinoacetic acid by using radioligand binding, absorption and fluorescence spectroscopy, computer-aided molecular modeling, and site-directed mutagenesis.
    Anchin JM; Droupadi PR; DuBois GE; Kellogg MS; Nagarajan S; Carter JS; Linthicum DS
    J Immunol; 1994 Oct; 153(7):3059-69. PubMed ID: 8089487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of superpotent sweetener ligands by a library of monoclonal antibodies.
    Anchin JM; Nagarajan S; Carter J; Kellogg MS; DuBois GE; Linthicum DS
    J Mol Recognit; 1997; 10(5):235-42. PubMed ID: 9587873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local and transmitted conformational changes on complexation of an anti-sweetener Fab.
    Guddat LW; Shan L; Anchin JM; Linthicum DS; Edmundson AB
    J Mol Biol; 1994 Feb; 236(1):247-74. PubMed ID: 7893280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrofluorimetric study of the intermolecular complexation of monoclonal antibodies with the high potency sweetener N-(p-cyanophenyl)-N'-(diphenylmethyl) guanidineacetic acid.
    Droupadi PR; Anchin JM; Meyers EA; Linthicum DS
    J Mol Recognit; 1992 Dec; 5(4):173-9. PubMed ID: 1339485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular probes for sweeteners: immunorecognition of superpotent guanidinium compounds.
    Carpenter R; Anchin JM; Linthicum DS
    Hybridoma; 1996 Feb; 15(1):17-21. PubMed ID: 9064282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural predictions of the binding site architecture for monoclonal antibody NC6.8 using computer-aided molecular modeling, ligand binding, and spectroscopy.
    Viswanathan M; Anchin JM; Droupadi PR; Mandal C; Linthicum DS; Subramaniam S
    Biophys J; 1995 Sep; 69(3):741-53. PubMed ID: 8519975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The three-dimensional structure of a complex of a murine Fab (NC10. 14) with a potent sweetener (NC174): an illustration of structural diversity in antigen recognition by immunoglobulins.
    Guddat LW; Shan L; Broomell C; Ramsland PA; Fan Z; Anchin JM; Linthicum DS; Edmundson AB
    J Mol Biol; 2000 Sep; 302(4):853-72. PubMed ID: 10993728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-induced domain movement in an antibody Fab: molecular dynamics studies confirm the unique domain movement observed experimentally for Fab NC6.8 upon complexation and reveal its segmental flexibility.
    Sotriffer CA; Liedl KR; Linthicum DS; Rode BM; Varga JM
    J Mol Biol; 1998 May; 278(2):301-6. PubMed ID: 9571052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocrystal structures of NC6.8 Fab identify key interactions for high potency sweetener recognition: implications for the design of synthetic sweeteners.
    Gokulan K; Khare S; Ronning DR; Linthicum SD; Sacchettini JC; Rupp B
    Biochemistry; 2005 Jul; 44(29):9889-98. PubMed ID: 16026161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the structure of the combining site of an antisweet taste ligand monoclonal antibody NC10.14.
    Viswanathan M; Subramaniam S; Pledger DW; Tetin SY; Linthicum DS
    Biopolymers; 1996 Sep; 39(3):395-406. PubMed ID: 8756519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable region sequence and characterization of monoclonal antibodies to a N,N',N"-trisubstituted guanidine high potency sweetener.
    Anchin JM; Linthicum DS
    Mol Immunol; 1993 Nov; 30(16):1463-71. PubMed ID: 8232332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption spectroscopy of the complexation between superpotent guanidinium sweeteners and specific monoclonal antibodies.
    Droupadi PR; Linthicum DS
    Int J Biochem Cell Biol; 1995 Apr; 27(4):351-7. PubMed ID: 7788557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-aided molecular modeling of the binding site architecture for eight monoclonal antibodies that bind a high potency guanidinium sweetener.
    Anchin JM; Mandal C; Culberson C; Subramaniam S; Linthicum DS
    J Mol Graph; 1994 Dec; 12(4):257-66, 289-90. PubMed ID: 7696216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
    Paula S; Monson N; Ball WJ
    Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the binding of the Fab fragment of monoclonal antibody NC10 to influenza virus N9 neuraminidase from tern and whale using the BIAcore biosensor: effect of immobilization level and flow rate on kinetic analysis.
    Kortt AA; Nice E; Gruen LC
    Anal Biochem; 1999 Aug; 273(1):133-41. PubMed ID: 10452809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of correlated motion in antibody combining sites from molecular dynamics simulations.
    Viswanathan M; Linthicum DS; Subramaniam S
    Methods; 2000 Mar; 20(3):362-71. PubMed ID: 10694457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of important residues in metal-chelate recognition by monoclonal antibodies.
    Delehanty JB; Jones RM; Bishop TC; Blake DA
    Biochemistry; 2003 Dec; 42(48):14173-83. PubMed ID: 14640685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
    Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
    J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.